| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -2% |
| 3Y CAGR | +2% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +5% |
| 3Y CAGR | +5% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,515.20 +12.70 (0.51%) | 19,010.91 | 28.04 | 5.64 | ||
PfizerPFIZER | ₹3,928.90 +11.00 (0.28%) | 17,930.59 | 20.86 | 4.09 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,572.50 +58.00 (0.89%) | 16,280.50 | 91.61 | 18.52 | ||
Natco PharmaNATCOPHARM | ₹814.55 +10.20 (1.27%) | 15,772.88 | 13.78 | 1.5 |